Alcoa/Kobe Steel Joint Venture Developments

Alcoa and Kobe Steel have announced that they will terminate their joint venture aluminium plants that produce aluminium can stock used in beverage cans. This decision has been undertaken as the joint ventures did not meet the expectations of either party.

The termination will affect two joint ventures, which were owned 50/50 between the two. Alcoa has agreed to hand over control of the Kaal Japan joint venture, while they will take over Kobe’s share of the Kaal Australia operation. Financial details of the transaction were not disclosed.

Alcoa will also grant Kobe a licence for cold rolling technology as used in the rolling mill in the Japanese operations, and will also act as a distributor for their can sheet products in Asia.

Despite terminating their can stock joint ventures, the two parties have agreed to expand their co-operative efforts developing aluminium products for the automotive market. This will be achieved by adding research and development efforts for aluminium extrusions, castings and forgings.

These added activities will enhance sheet activities provided by 50/50 joint ventures Kobe Alcoa Transportation Products in Japan and Alcoa Kobe Transportation Products in America formed in 1992.

For more information aluminium, click here.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Kobe Steel. (2019, March 19). Alcoa/Kobe Steel Joint Venture Developments. AZoM. Retrieved on November 21, 2024 from https://www.azom.com/news.aspx?newsID=750.

  • MLA

    Kobe Steel. "Alcoa/Kobe Steel Joint Venture Developments". AZoM. 21 November 2024. <https://www.azom.com/news.aspx?newsID=750>.

  • Chicago

    Kobe Steel. "Alcoa/Kobe Steel Joint Venture Developments". AZoM. https://www.azom.com/news.aspx?newsID=750. (accessed November 21, 2024).

  • Harvard

    Kobe Steel. 2019. Alcoa/Kobe Steel Joint Venture Developments. AZoM, viewed 21 November 2024, https://www.azom.com/news.aspx?newsID=750.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.